Literature DB >> 6234951

Impaired erythrocyte calcium homeostasis in beta-thalassemia.

O Shalev, S Mogilner, E Shinar, E A Rachmilewitz, S L Schrier.   

Abstract

Intracellular calcium (Ca) concentration in erythrocytes (RBCs) is controlled by a low passive influx through a relatively impermeable membrane and by active efflux catalyzed by Ca2+,Mg2+-ATPase. Since precipitation of alpha-globin chains in thalassemic RBCs may interfere with normal membrane function, we studied the RBC intracellular Ca content and the RBC membrane Ca2+,Mg2+-ATPase activity in two groups of patients with nonsplenectomized (n = 9) and splenectomized (n = 9) beta-thalassemia intermedia and in two groups of matched controls. The mean +/- SD Ca concentration in the nonsplenectomized (n = 12) and splenectomized (n = 6) controls were 6.1 +/- 6.0 and 5.8 +/- 3.4 mumol Ca per liter of RBCs, respectively, compared with 26.0 +/- 7.6 (P less than .001) and 85 +/- 24.4 (P less than .001) in the nonsplenectomized and splenectomized thalassemia patients, respectively. The mean +/- SD Ca2+,Mg2+-ATPase activity in the eight nonsplenectomized patients was 0.77 +/- 0.58 mumol inorganic phosphate (Pi) per milligram of protein per hour compared with 0.66 +/- 0.41 in the controls (P = NS). Similar values were obtained for the splenectomized patients and their controls. No correlation was found between either the intracellular Ca content or the Ca2+,Mg2+-ATPase activity with the peripheral nucleated RBC count. These findings suggest that there is a major defect in the membrane of the thalassemic RBC leading to an increased Ca content that is more pronounced in splenectomized patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234951

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  Thalassemia: genotypes and phenotypes.

Authors:  D Loukopoulos
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

Review 2.  Thalassemia: genotypes and phenotypes.

Authors:  D Loukopoulos
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

Review 3.  Calcium homeostasis of human erythrocytes and its pathophysiological implications.

Authors:  B Engelmann
Journal:  Klin Wochenschr       Date:  1991-02-26

4.  Isolation and partial characterization of antibody- and globin-enriched complexes from membranes of dense human erythrocytes.

Authors:  R Kannan; J Yuan; P S Low
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

5.  A mechanism of ineffective erythropoiesis in β-thalassemia/Hb E disease.

Authors:  Pathrapol Lithanatudom; Amporn Leecharoenkiat; Tirawat Wannatung; Saovaros Svasti; Suthat Fucharoen; Duncan R Smith
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

6.  Intracellular calcium content of human erythrocytes: relation to sodium transport systems.

Authors:  B Engelmann; J Duhm
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

7.  Alterations in Ca2+ homeostasis in rat erythrocytes with atrazine treatment: positive modulation by vitamin E.

Authors:  Mohan Singh; Rajat Sandhir; Ravi Kiran
Journal:  Mol Cell Biochem       Date:  2010-02-27       Impact factor: 3.396

8.  Modulation of erythrocyte membrane material properties by Ca2+ and calmodulin. Implications for their role in regulation of skeletal protein interactions.

Authors:  Y Takakuwa; N Mohandas
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

9.  Morphologically homogeneous red blood cells present a heterogeneous response to hormonal stimulation.

Authors:  Jue Wang; Lisa Wagner-Britz; Anna Bogdanova; Sandra Ruppenthal; Kathrina Wiesen; Elisabeth Kaiser; Qinghai Tian; Elmar Krause; Ingolf Bernhardt; Peter Lipp; Stephan E Philipp; Lars Kaestner
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

Review 10.  Calcium in red blood cells-a perilous balance.

Authors:  Anna Bogdanova; Asya Makhro; Jue Wang; Peter Lipp; Lars Kaestner
Journal:  Int J Mol Sci       Date:  2013-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.